Skip to content

Clinical trials

Alzheimer Disease trials in Italy with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Not applicable Country / region: Italy Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20102
20121
20131
20152
20162
20171
20184
20192
20201
20216
20225
20236
20244
20256
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting12
Unknown status8
Active, not recruiting5
Not yet recruiting2
Terminated1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Centro San Giovanni di Dio Fatebenefratelli6
I.R.C.C.S. Fondazione Santa Lucia4
Istituto Nazionale di Ricovero e Cura per Anziani4
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia3
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
IRCCS Centro Neurolesi Bonino Pulejo3
IRCCS San Raffaele3
Fondazione Don Carlo Gnocchi ETS2
Universita di Verona2
Azienda Ospedaliera di Perugia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease50
Cognitive Dysfunction12
Dementia9
Parkinson Disease4
Multiple Sclerosis2
Neurodegenerative Diseases2
Obesity2
Pick Disease of the Brain2
Agnosia1
Amyloid Neuropathies, Familial1

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.